Business Description
Agilon Health Inc
NAICS : 623312
SIC : 8099
Description
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.44 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 7.86 | |||||
| Beneish M-Score | -1.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y Total Revenue Growth Rate | 46.79 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.88 | |||||
| 9-Day RSI | 73.19 | |||||
| 14-Day RSI | 68.96 | |||||
| 6-1 Month Momentum % | -35.52 | |||||
| 12-1 Month Momentum % | -2.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.48 | |||||
| Quick Ratio | 2.48 | |||||
| Cash Ratio | 1.46 | |||||
| Days Sales Outstanding | 72.17 | |||||
| Days Payable | 80.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 4.51 | |||||
| Operating Margin % | -4 | |||||
| Net Margin % | -4.3 | |||||
| ROE % | -9.67 | |||||
| ROA % | -6.04 | |||||
| ROIC % | -40.53 | |||||
| ROC (Joel Greenblatt) % | -266.88 | |||||
| ROCE % | -8.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 146.53 | |||||
| PS Ratio | 3.66 | |||||
| PB Ratio | 8.33 | |||||
| Price-to-Tangible-Book | 9.21 | |||||
| EV-to-EBIT | -77.97 | |||||
| EV-to-EBITDA | -89.69 | |||||
| EV-to-Revenue | 3.25 | |||||
| EV-to-Forward-Revenue | 2.09 | |||||
| EV-to-FCF | -51.14 | |||||
| Price-to-Net-Current-Asset-Value | 10.68 | |||||
| Price-to-Net-Cash | 52.38 | |||||
| Earnings Yield (Greenblatt) % | -1.28 |
